Authors: Martha Powell, Future Science Group
Pick of the Posters
- ‘Antimicrobial activity of Ceftobiprole when tested against Gram-positive cocci causing serious infections (2016-2017): Endocarditis, diabetic foot, and bone/ joint infections’ by first author M A Pfaller (JMI Laboratories, IA, USA), one of Future Microbiology’s Editorial Board Members. This poster reported the potent activity of Ceftobiprole against contemporary clinically relevant Gram-positive isolates causing serious infections and most importantly, 99.% of the S. aureus isolates (39.4% MRSA) were susceptible.
- ‘Predicting Carbapenem resistance among Gram-negative pathogens in complicated urinary tract infections’ by lead author M. D. Zilberberg from EviMed Res. Group (MA, USA) describes a simple tool to guide clinicians in the management of carbapenem-resistant complicated urinary tract infections.
Catch up with all our daily updates:
Picture of the Day
Today at our booth
Today was sadly our last day exhibiting at ASM Microbe – it’s been a great few days and we’ve met lots of fantastic people. We’re already looking forward to next year!
Remember to sign up for Infectious Diseases Hub, or follow out Twitter updates @IDHubFSG
Best of social media #ASMicrobe
Dr. Jeffrey Malone dissecting c-di-GMP signaling and ribosomal modifications in Pseudomonas. Elegant work, plus I love a talk that builds the working model as the talk progresses. #ASMicrobe
— Flavia Costa (@Alderaanenzymes) June 10, 2018
— Patricia Akrivoulis (@akrivoulis) June 10, 2018